The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 161-170

  Cartmell, Jayne ^a   Monn, James A ^a   Schoepp, Darryle D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (2 CARBOXYPROPAN 1 YL) 3 (DIBENZOPYRAN 4 YL)PROPANOIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; CLOZAPINE; DEXAMPHETAMINE; DOPAMINE; EGLUMETAD; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; HALOPERIDOL; METABOTROPIC RECEPTOR; PHENCYCLIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT;

AMINO ACIDS; ANIMALS; BICYCLO COMPOUNDS; BICYCLO COMPOUNDS, HETEROCYCLIC; DEXTROAMPHETAMINE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; PHENCYCLIDINE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 0032848507     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Adams B and Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554.
2. Anis NA, Berry SC, Burton NR and Lodge D (1983) The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 79:565-575.
3. Attarian S and Amalric M (1997) Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat. Eur J Neurosci 9:809-816.
4. Battaglia G, Monn JA and Schoepp DD (1997) In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neurosci Lett 229:161-164.
5. Bond A, O'Neill MJ, Hicks CA, Monn JA and Lodge D (1998) Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischemia. Neuroreport 9:1191-1193.
6. Chou T-C and Talalay P (1983) Analysis of combined drug effects: A new look at a very old problem. Trends Pharmacol Sci 11:450-454.
7. Conn PJ and Pin J-P (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237.
8. Danysz W, Parsons CG, Bresink I and Quack G (1995) Glutamate in CNS disorders. Drug News Perspect 8:261-277.
9. Del Rio J and Fuentes JA (1969) Further studies on the antagonism of stereotyped behaviour induced by amphetamine. Eur J Pharmacol 8:73-78.
10. Dube GR and Marshall KC (1997) Modulation of excitatory synaptic transmission in locus coeruleus by multiple presynaptic metabotropic glutamate receptors. Neuroscience 80:511-521.
11. Forsythe ID and Barnes-Davies M (1997) Synaptic transmission: Well placed modulators. Curr Biol 7:R362-R365.
12. Geyer MA and Braff DL (1987) Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull 13:643-668.
13. Halberstadt AL (1995) The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 18:237-249.
14. Helton DR, Schoepp DD, Monn JA, Tizzano JP and Kallman MJ (1998a) A role for metabotropic glutamate receptors in drug withdrawal states, in Metabotropic Glutamate Receptors and Brain Function (Moroni F, Nicoletti F, Pellegrini-Giampietro DE eds) pp 305-314, Portland Press Ltd, London, UK.
15. Helton DR, Tizzano JP, Monn JA, Schoepp DD and Kallman MJ (1997) LY354740: A potent, orally active, highly selective metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal. Neuropharmacology 36:1511-1516.
16. Helton DR, Tizzano JP, Monn JA, Schoepp DD and Kallman MJ (1998b): Anxiolytic and side-effect profile of LY354740: A potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J Pharmacol Exp Ther 284:651-660.
17. Hernandez L, Auerbach S and Hoebel, BG (1988) Phencydidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis. Life Sci 42:1713-1723.
18. Hondo H, Yonezawa Y, Nakahara T, Nakamura K, Hirano M, Uchimura H and Tashiro N (1994) Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Res 633:337-342.
19. Iversen LL (1975) Dopamine receptors in the brain. Science (Wash DC) 188:1084-1089.
20. Javitt DC and Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
21. Jentsch JD and Roth RH (1999) The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201-225.
22. Kilbride J, Huang L-Q, Rowan MJ and Anwyl R (1998) Presynaptic inhibitory action of group II metabotropic glutamate receptor agonists, LY354740 and DCG-IV. Eur J Pharmacol 356:149-157.
23. Kim JH and Vezina P (1997) Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. J Pharmacol Exp Ther 283:962-968.
24. Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Belagaje R, Wu S and Schoepp DD (1998) LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37:1-12.
25. Knopfel T and Gasparini F (1996) Metabotropic glutamate receptors: Potential drug targets. Drug Dev Today 1:103-108.
26. Kronthaler UO and Schmidt WJ (1996) 1S,3R-ACPD has cataleptogenic effects and reverses MK-801-and less pronounced, D,L-amphetamine-induced locomotion. Eur J Pharmacol 316:129-136.
27. Kronthaler UO and Schmidt WJ (1998) The mGluRs group II agonist (2S,3S,4S)-alpha-carboxycyclopropyl-glycine induces catalepsy in the rat, which is pronouncedly anatgonised by dizoclipine and D,L-amphetamine. Neurosci Lett 253:25-28.
28. Kuczenski R and Segal D (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051-2065.
29. Lillrank SM, O'Connor WT, Saransaari P and Ungerstedt U (1994) In vivo effects of local and systemic phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of anaesthitized rats. Acta Physiol Scand 150:109-115.
30. Ljungberg T and Ungerstedt U (1985) A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs. Pharmacol Biochem Behav 23:479-485.
31. Lovinger DM and McCool BA (1995) Metabotropic glutamate receptor-mediated preysnaptic depression at corticostriatal synapses involves mGluR2 or 3. J Neurophysiol 73:1076-1083.
32. Macek TA, Winder DG, Gereau RW, Ladd CO and Conn PJ (1996) Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses. J Neurophysiol 76:3798-3806.
33. Marek GJ and Aghajanian GK (1998) The electrophysiology of prefrontal serotonin systems: Therapeutic implications for mood and psychosis. Biol Psychiatry 44:1118-1127.
34. Moghaddam B and Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonists in rats. Science (Wash DC) 281:1349-1352.
35. Monn JA, Valli MJ, Massey SM, Hansen MM, Kress TJ, Wepsiec JP, Harkness AR, Grutsch JL, Wright RA, Johnson BG, Andis SL, Kingston A, Tomlinson R, Lewis R, Griffey KR, Tizzano JP and Schoepp DD (1999) Synthesis, pharmacological characterization and molecular modeling of heterobicyclic amino acids related to LY354740: Identification of two new potent, selective and systemically active agonists for group II metabotropic glutamate receptors. J Med Chem 42:1027-1040.
36. Monn JA, Valli MJ, Massey SM, Wright RA, Salhoff CR, Johnson BG, Howe T, Alt CA, Rhodes GA, Robey RL, Griffey KR, Tizzano JP, Kallman MJ, Helton DR and Schoepp DD (1997) Design, synthesis and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: A potent, selective, systemically active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J Med Chem 40:528-637.
37. Mueller K (1993) Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine. Pharmacol Biochem Behav 45:71-76.
38. Murray TF and Horita A (1979) Phencyclidine-induced stereotyped behavior in rats: Dose response effects and antagonism by neuroleptics. Life Sci 24:2217-2226.
39. Nakanishi S (1992) Molecular diversity of glutamate receptors and implications for brain function. Science (Wash DC) 268:597-603.
40. Neki A, Ohishi H, Kaneko T, Shigemoto R, Nakanishi S and Mizuno N (1996) Pre-and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: An immunohistochemical study with a monoclonal antibody. Neurosci Lett 202:197-200.
41. Neugebauer V, Keele NB and Shinnick-Gallagher P (1997) Epileptogenesis in vivo enhances the sensitivity of inhibitory presynaptic metabotropic glutamate receptors in basolateral amygdala neurons in vitro. J Neurosci 17:983-995.
42. Nicoletti F, Bruno V, Copani A, Casabona G and Knopfel T (1996) Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders? Trends Neurosci 19:267-271.
43. Ohishi H, Ogawa-Meguro R, Shigemoto R, Kaneko T, Nakanishi S and Mizuno N (1994) Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex. Neuron 13:55-66.
44. Ohishi H, Shigemoto R, Nakanishi S and Mizuno N (1993a) Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53:1009-1018.
45. Ohishi H, Shigemoto R, Nakanishi S and Mizuno N (1993b) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study. J Comp Neurol 335:252-266.
46. Ornstein PL, Bleisch TJ, Arnold MB, Wright RA, Johnson BG and Schoepp DD (1998) 2-Substituted 2SR-2-amino-2-(1SR,2SR-2-carboxycyclopropan-1-yl)glycines as potent and selective antagonists of group 2 metabotropic glutamate receptors. Part 1: Effects of alkyl, arylalkyl and diarylalkyl substitution. J Med Chem 41:346-357.
47. Konieczny J, Ossowska K, Wolfarth S and Pilc A (1998) LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats. Naunyn-Schmiedeberg's Arch Pharmacol 358:500-502.
48. Pin JP and Duvoisin R (1995) The metabotropic glutamate receptors: Structure and functions. Neuropharmacology 34:1-26.
49. Robertson A and MacDonald C (1984) Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy. Pharmacol Biochem Behav 21:97-101.
50. Scanziani M, Salin PA, Vogt KE, Malenka RC and Nicoll RA (1997) Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature (Lond) 385:630-634.
51. Schoepp DD, Johnson BG, Wright RA, Salhoff CR, Mayne NG, Wu S, Cockerham SL, Burnett JP, Belagaje R, Bleakman D and Monn JA (1997) LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology 36:1-11.
52. Seeman P (1995) Dopamine receptors: Clinical correlates, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 295-302, Raven Press, New York.
53. Seiden LS, Sabol KE and Ricaurte GA (1993) Amphetamine: Effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 32:639-677.
54. Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ, Neki A, Abe T, Nakanishi S and Mizuno N (1997) Differential presynaptic localizations of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci 17:7503-7522.
55. Steinpreis RE (1996) The behavioral and neurochemical effects of phencyclidine in humans and animals: Some implications for modeling psychosis. Behavioral Brain Res 74:45-65.
56. Sturgeon RD, Fessler RG, Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59:169-179.
57. Thornberg SA and Saklad SR (1996) A review of NMDA receptors and the phencyclidine model of schizophrenia. Pharmacotherapy 16:82-93.
58. Tschanz JT and Rebec GV (1989) Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy. Pharmacol Biochem Behav 81:519-522.